Cargando…

KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 Signalling

Aims: Krüppel-like Factor 9 (KLF9) is a transcription factor that regulates multiple disease processes. Studies have focused on the role of KLF9 in the redox system. In this study, we aimed to explore the effect of KLF9 on diabetic cardiomyopathy. Methods and Results: Cardiac-specific overexpression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fangfang, Peng, Jingfeng, Feng, Hui, Yang, Yiming, Gao, Jianbo, Liu, Chunrui, Xu, Jie, Zhao, Yanru, Pan, Siyu, Wang, Yixiao, Xu, Luhong, Qian, Wenhao, Zong, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656075/ https://www.ncbi.nlm.nih.gov/pubmed/36359788 http://dx.doi.org/10.3390/cells11213393

Ejemplares similares

The Relationship between the Serum NLRP1 Level and Coronary Lesions in Patients with Coronary Artery Disease
por: Zong, Jing, et al.
Publicado: (2023)

Zinc Finger Protein ZBTB20 protects against cardiac remodelling post‐myocardial infarction via ROS‐TNFα/ASK1/JNK pathway regulation
por: Li, Fangfang, et al.
Publicado: (2020)

αCGRP deficiency aggravates pulmonary fibrosis by activating the PPARγ signaling pathway
por: Lv, Xiaoting, et al.
Publicado: (2023)

Reduced fatty acid uptake aggravates cardiac contractile dysfunction in streptozotocin-induced diabetic cardiomyopathy
por: Umbarawan, Yogi, et al.
Publicado: (2020)

KLF13 promotes porcine adipocyte differentiation through PPARγ activation
por: Jiang, Shuzhong, et al.
Publicado: (2015)

Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers
por: Loft, Anne, et al.
Publicado: (2015)

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
por: Wu, Meng, et al.
Publicado: (2018)

Global Deletion of the Prolactin Receptor Aggravates Streptozotocin-Induced Diabetes in Mice
por: Ramirez-Hernandez, Gabriela, et al.
Publicado: (2021)

Long isoforms of NRF1 negatively regulate adipogenesis via suppression of PPARγ expression
por: Xue, Peng, et al.
Publicado: (2019)

KLF13 Loss‐of‐Function Mutations Underlying Familial Dilated Cardiomyopathy
por: Guo, Yu‐Han, et al.
Publicado: (2022)

PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO
por: Polvani, Simone, et al.
Publicado: (2012)

Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021)

EZH2‐mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ
por: Du, Zhipeng, et al.
Publicado: (2021)

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Liu, Wenjuan, et al.
Publicado: (2018)

Orientin Reduces Myocardial Infarction Size via eNOS/NO Signaling and Thus Mitigates Adverse Cardiac Remodeling
por: Li, Fangfang, et al.
Publicado: (2017)

Flavonoids as Putative Inducers of the Transcription Factors Nrf2, FoxO, and PPARγ
por: Pallauf, Kathrin, et al.
Publicado: (2017)

KLF15 and PPARα Cooperate to Regulate Cardiomyocyte Lipid Gene Expression and Oxidation
por: Prosdocimo, Domenick A., et al.
Publicado: (2015)

Naproxen aggravates doxorubicin-induced cardiomyopathy in rats
por: Pathan, Rahila Ahmad, et al.
Publicado: (2010)

Nrf2 deficiency aggravates PM(2.5)-induced cardiomyopathy by enhancing oxidative stress, fibrosis and inflammation via RIPK3-regulated mitochondrial disorder
por: Ge, Chenxu, et al.
Publicado: (2020)

Klf4-Sirt3/Pparα-Lcad pathway contributes to high phosphate-induced lipid degradation
por: Yu, Angen, et al.
Publicado: (2023)

The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
por: Jiang, Tao, et al.
Publicado: (2010)

A KDM6A–KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction
por: Lin, Chun‐Liang, et al.
Publicado: (2019)

MiR-200c-3p aggravates gastric cell carcinoma via KLF6
por: Wang, Ying, et al.
Publicado: (2021)

Exposure of Fluoride with Streptozotocin-Induced Diabetes Aggravates Testicular Damage and Spermatozoa Parameters in Mice
por: Sánchez-Gutiérrez, Manuel, et al.
Publicado: (2019)

KLF2 Inhibits Chicken Preadipocyte Differentiation at Least in Part via Directly Repressing PPARγ Transcript Variant 1 Expression
por: Cui, Tingting, et al.
Publicado: (2021)

Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway
por: Lu, Ying, et al.
Publicado: (2018)

Low‐dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter
por: Shao, Xia, et al.
Publicado: (2023)

Antioxidant Potential of Adiponectin and Full PPAR-γ Agonist in Correcting Streptozotocin-Induced Vascular Abnormality in Spontaneously Hypertensive Rats
por: Afzal, Sheryar, et al.
Publicado: (2021)

Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats
por: Atta, Mustafa S., et al.
Publicado: (2018)

DNMT1-mediated PPARα methylation aggravates damage of retinal tissues in diabetic retinopathy mice
por: Zhu, Ying, et al.
Publicado: (2021)

Esculeoside A Decreases Diabetic Cardiomyopathy in Streptozotocin-Treated Rats by Attenuating Oxidative Stress, Inflammation, Fibrosis, and Apoptosis: Impressive Role of Nrf2
por: ALTamimi, Jozaa Z., et al.
Publicado: (2023)

Absence of Intestinal PPARγ Aggravates Acute Infectious Colitis in Mice through a Lipocalin-2–Dependent Pathway
por: Kundu, Parag, et al.
Publicado: (2014)

Co-exposure to multi-walled carbon nanotube and lead ions aggravates hepatotoxicity of nonalcoholic fatty liver via inhibiting AMPK/PPARγ pathway
por: Liu, Enqin, et al.
Publicado: (2020)

KLF15 Loss-of-Function Mutation Underlying Atrial Fibrillation as well as Ventricular Arrhythmias and Cardiomyopathy
por: Li, Ning, et al.
Publicado: (2021)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
por: Zheng, Hongting, et al.
Publicado: (2011)

MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
por: Yin, Zhongwei, et al.
Publicado: (2019)

Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug-Induced Oxidative Injury
por: Lee, Choongho
Publicado: (2017)

KLF2 Protects against Osteoarthritis by Repressing Oxidative Response through Activation of Nrf2/ARE Signaling In Vitro and In Vivo
por: Gao, Xiang, et al.
Publicado: (2019)

Syringic Acid Attenuates Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Sabahi, Zahra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k98m3vfq4ldqv7jvjl979i5snk